Bottom line
NMAVX vs VOT: the short answer
NMAVX (Nuance Mid Cap Value Fund) and VOT (Vanguard Mid-Cap Growth Index Fund) are both mutual funds.
But VOT is far broader, holding 127 positions to 62 for NMAVX, so beyond the top names it adds exposure NMAVX doesn't have.
VOT is cheaper at 0.05% vs 1.21% — a difference of $116 a year per $10,000 invested.
Over five years, VOT returned +6.4% a year vs +3.1% for NMAVX.
NMAVX has a front-end sales load of up to 5%; the other does not.
Updated Nov 19, 2026
NMAVX vs VOT side by side
| NMAVX | VOT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Tortoise | Vanguard |
| Category | Mid-Cap | Mid-Cap |
| Expense ratio | 1.21% | 0.05% |
| Annual cost per $10k | $121 | $5 |
| 10-yr cost on $10k (prospectus) | $2,002 | $64 |
| Max front load | 5% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −1.4% | +10.7% |
| 5-yr return (annualized) | +3.1% | +6.4% |
| 10-yr return (annualized) | +7.6% | +11.6% |
| Best quarter | +15.3% | +30.6% |
| Worst quarter | −19.3% | −21.2% |
| Net assets (fund) | $294.8M | $34.8B |
| Number of holdings | 62 | 127 |
| Portfolio turnover | 11% | 17% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
NMAVX and VOT share none of their top holdings.
NMAVX top 10
- Qiagen Nv — 7.19%
- First American Government Obli — 6.60%
- California Water Service Group — 5.82%
- Beiersdorf AG — 5.70%
- Clorox Co/The — 5.27%
- Kenvue Inc — 3.48%
- Charles Schwab Corp — 3.37%
- Solventum Corp — 3.01%
- Bio-Techne Corp — 2.98%
- Henkel AG & Co KGaA — 2.78%
VOT top 10
- Vertiv Holdings Co — 2.83%
- Western Digital Corp — 2.42%
- Seagate Technology Holdings PLC — 2.38%
- Quanta Services Inc — 2.38%
- Howmet Aerospace Inc — 2.37%
- Datadog Inc — 1.90%
- Bloom Energy Corp — 1.80%
- Constellation Energy Corp — 1.77%
- Robinhood Markets Inc — 1.75%
- Cloudflare Inc — 1.72%
FAQ
What is the difference between NMAVX and VOT?
Which is cheaper, NMAVX or VOT?
Should I own both NMAVX and VOT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.